Prescription-drug sales in emerging markets will reach $400B in 2020, according to IMS; this is roughly the same amount as the current combined sales in the US and the big-5 countries of Europe (Germany, France, UK, Italy, Spain).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.